A major breakthrough in cancer study is occurring with the use of mini-antibodies to restore dysfunctional p53. This crucial malignant protector protein is frequently disabled in many forms of cancer, causing https://bookmarkpagerank.com/story22003745/mini-antibodies-reactivate-the-p53-protein-a-potential-pathway-for-tumor-treatment